 |
|
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol. 2017;23(2):128-137. Published online 2017 May 10 DOI: https://doi.org/10.3350/cmh.2016.0071
|
|
Citations to this article as recorded by
 Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis
Shun-An Zhou, Qing-Mei Zhou, Lei Wu, Zhi-Hong Chen, Fan Wu, Zhen-Rong Chen, Lian-Qun Xu, Bi-Ling Gan, Hao-Sheng Jin, Ning Shi
World Journal of Gastrointestinal Oncology.2024; 16(8): 3672. CrossRef Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Nandini Gupta, Neelkant Verma, Bhoomika Patel
Journal of Gastrointestinal Cancer.2024; 55(4): 1485. CrossRef Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
Wei Zhang, Deliang Ouyang, Zhangkan Huang, Xu Che
Frontiers in Oncology.2023;[Epub] CrossRef Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao
Hepatobiliary & Pancreatic Diseases International.2022; 21(2): 134. CrossRef A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study
Juxian Sun, Chang Liu, Jie Shi, Nanya Wang, Dafeng Jiang, Feifei Mao, Jingwen Gu, Liping Zhou, Li Shen, Wan Yee Lau, Shuqun Cheng
Chinese Medical Journal.2022; 135(19): 2338. CrossRef Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study
Dong Hyun Sinn, Hye Won Lee, Yong-Han Paik, Do Young Kim, Yoon Jun Kim, Kang Mo Kim, Si Hyun Bae, Ji Hoon Kim, Yeon Seok Seo, Jae Young Jang, Byoung Kuk Jang, Hyung Joon Yim, Hyung Joon Kim, Byung Seok Lee, Bo Hyun Kim, In Hee Kim, Eun-Young Cho, Jung Il
Digestive Diseases and Sciences.2021; 66(1): 315. CrossRef Survival in untreated hepatocellular carcinoma: A national cohort study
Young Ae Kim, Danbee Kang, Hyeyoung Moon, Donghyun Sinn, Minwoong Kang, Sang Myung Woo, Yoon Jung Chang, Boram Park, Sun-Young Kong, Eliseo Guallar, Soo-Yong Shin, Geunyeon Gwak, Joung Hwan Back, Eun Sook Lee, Juhee Cho, Gianfranco D. Alpini
PLOS ONE.2021; 16(2): e0246143. CrossRef Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
Linda Beenet
Clinical Colorectal Cancer.2021; 20(3): e194. CrossRef Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments
Hiroyuki Suzuki, Hideki Iwamoto, Masahito Nakano, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Dan Nakano, Ryoko Kuromatsu, Takashi Niizeki, Shusuke Okamura, Shigeo Shimose, Tomotake Shirono, Yu Noda, Naoki Kamachi, Hirohisa Yano, A
Translational Oncology.2021; 14(11): 101201. CrossRef The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Shengzhou Li, Jiaxuan Xu, Hongya Zhang, Jiaze Hong, Yuexiu Si, Tong Yang, Yujing He, Derry Minyao Ng, Dingcheng Zheng
Chemotherapy.2021; 66(4): 124. CrossRef Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis
Miao Liu, Junyi Shi, Tong Mou, Yang Wang, Zhongjun Wu, Ai Shen
Journal of Gastroenterology and Hepatology.2020; 35(8): 1277. CrossRef Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy
Pil Soo Sung, Moon Hyung Choi, Hyun Yang, Soon Kyu Lee, Ho Jong Chun, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Joon-Il Choi, Young Joon Lee, Si Hyun Bae
Frontiers in Oncology.2020;[Epub] CrossRef ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma
Tongwang Yang, Yuxue Gao, Daojie Liu, Yang Wang, Jing Wu, Xiaoni Liu, Ying Shi, Dexi Chen
Biochemical and Biophysical Research Communications.2019; 508(3): 769. CrossRef Selective embolization with magnetized microbeads using magnetic resonance navigation in a controlled‐flow liver model
François Michaud, Ning Li, Rosalie Plantefève, Zeynab Nosrati, Charles Tremblay, Katayoun Saatchi, Gerald Moran, Alexandre Bigot, Urs O. Häfeli, Samuel Kadoury, An Tang, Pierre Perreault, Sylvain Martel, Gilles Soulez
Medical Physics.2019; 46(2): 789. CrossRef Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
Cem Simsek, Ece Esin, Suayib Yalcin
Journal of Oncology.2019; 2019: 1. CrossRef Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
Bo-wen Zhuang, Wei Li, Xiao-hua Xie, Hang-tong Hu, Ming-de Lu, Xiao-yan Xie
Japanese Journal of Clinical Oncology.2019; 49(9): 845. CrossRef Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment
Guofei Li, Limei Zhao
Drug Delivery.2019; 26(1): 756. CrossRef Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani
World Journal of Gastroenterology.2019; 25(31): 4360. CrossRef Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma
Min Kyu Kang, Jung Gil Park, Heon Ju Lee
Medicine.2018; 97(17): e0611. CrossRef Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho
Cancer Chemotherapy and Pharmacology.2018; 82(3): 469. CrossRef Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
Roberto Filippi, Pasquale Lombardi, Ilaria Depetris, Elisabetta Fenocchio, Virginia Quarà, Giovanna Chilà, Massimo Aglietta, Francesco Leone
Expert Opinion on Pharmacotherapy.2018; 19(13): 1451. CrossRef Liver‑targeted delivery of liposome‑encapsulated curcumol using galactosylated‑stearate
Wen‑Jie Li, You‑Wen Lian, Quan‑Sheng Guan, Ning Li, Wen‑Jun Liang, Wen‑Xin Liu, Yong‑Bin Huang, Yi Cheng, Hui Luo
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clinical and Molecular Hepatology.2017; 23(2): 123. CrossRef
|